Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy
European Journal of Neurology · 2024
DOI: 10.1111/ene.16192 ↗At a glance
Journal article in European Journal of Neurology, 2024. Written by Panoraia Baka and 10 co-authors. Institution: Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. Major MEDLINE topics: Small Fiber Neuropathy, Peripheral Nervous System Diseases. Cited 13 times so far (Crossref); 72 references. The full text is freely available (open access, CC BY 4.0). Funded by: Deutsche Forschungsgemeinschaft.
Abstract (original language)
Background and purpose Diagnosing small fiber neuropathies can be challenging. To address this issue, whether serum neurofilament light chain (sNfL) could serve as a potential biomarker of damage to epidermal Aδ‐ and C‐fibers was tested.
Methods
Serum NfL levels were assessed in 30 patients diagnosed with small fiber neuropathy and were compared to a control group of 19 healthy individuals. Electrophysiological studies, quantitative sensory testing and quantification of intraepidermal nerve fiber density after skin biopsy were performed in both the proximal and distal leg.
Results
Serum NfL levels were not increased in patients with small fiber neuropathy compared to healthy controls (9.1 ± 3.9 and 9.4 ± 3.8, p = 0.83) and did not correlate with intraepidermal nerve fiber density at the lateral calf or lateral thigh or with other parameters of small fiber impairment.
Conclusion
Serum NfL levels cannot serve as a biomarker for small fiber damage.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
- Department of Neurology, University Hospital of Würzburg, Würzburg, Germany.
- Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
ORCID profiles: Panoraia Baka
Funding
- Deutsche Forschungsgemeinschaft
Cite
APA
Baka, P., Steenken, L., Escolano-Lozano, F., Steffen, F., Papagianni, A., Sommer, C., Pogatzki-Zahn, E., Hirsch, S., Protopapa, M., Bittner, S., & Birklein, F. (2024). Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy. European Journal of Neurology. https://doi.org/10.1111/ene.16192
Vancouver
Baka P, Steenken L, Escolano-Lozano F, Steffen F, Papagianni A, Sommer C, et al. Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy. European Journal of Neurology. 2024. doi:10.1111/ene.16192
BibTeX
@article{Baka2024,
author = {Baka, Panoraia and Steenken, Livia and Escolano-Lozano, Fabiola and Steffen, Falk and Papagianni, Aikaterini and Sommer, Claudia and Pogatzki-Zahn, Esther and Hirsch, Silke and Protopapa, Maria and Bittner, Stefan and Birklein, Frank},
title = {Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy},
journal = {European Journal of Neurology},
year = {2024},
doi = {10.1111/ene.16192}
}
EUVIMED